Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/12/2026
China Indicts AstraZeneca and Former China Head Leon Wang Over Data an...
2/12/2026
UniXell Raises Over CNY 50M in Series A+ to Advance Stem Cell Therapy ...
2/12/2026
Lilly China's Mounjaro Approved for Type 2 Diabetes Monotherapy
2/12/2026
Lilly's Jaypirca Approved in China for Previously Treated CLL and SLL ...
2/12/2026
RemeGen Advances PD-1/VEGF BsAb RC148 Into Phase 3 Trials
2/12/2026
Ascletis Picks Oral Amylin Agonist ASC36 for Obesity Development, Plan...
2/12/2026
CDE Issues Draft Pharmaceutical Guidance for Rare Disease Chemical Dru...
2/12/2026
Today's China Crucible: What It Means for Pharma (PharmExec)
2/12/2026
China NMPA Approves Nine New Drugs in January 2026, Expanding Beyond O...
2/11/2026
NHSA Issues Trial Measures for Early Communication on Reference Drugs
2/11/2026
GSK's RSV Vaccine Arexvy Moves Forward in China
2/11/2026
China Eyes Approval for Russian Cancer Vaccine 'Enteromix'
2/11/2026
Shiling Pharma Targets 2028 for Nasal Spray Version of Wegovy Obesity ...
2/11/2026
Sanofi Backs GluBio's Molecular Glue Pill for Sickle Cell Disease
2/11/2026
Madrigal Expands MASH Pipeline with Six siRNA Programs from China's Ri...
2/11/2026
TenNor Therapeutics Files for Hong Kong IPO as Dual-Core Antibiotic Pi...
2/11/2026
Regend Raises CNY 350M Series C to Advance Cell-Based Organ Regenerati...
2/11/2026
Betta Pharma Wins China Approval for Pertuzumab Biosimilar in Breast C...
2/11/2026
Eli Lilly's Omvoh Approved in China for Crohn's Disease and Ulcerative...
2/11/2026
China Issues Revised Rules for National Essential Drug List Management
2/10/2026
3D Medicines Advances Envafolimab Toward Full Market Approval in China
2/10/2026
Cascade Raises $72M to Advance MASH, Obesity and Diabetes Pipeline
2/10/2026
Hengrui and Kailera Advance Obesity Therapy After Encouraging Mid-Stag...
2/10/2026
Insilico and CMS Partner on AI-Driven CNS and Autoimmune Drug Programs
2/10/2026
Weekly China Regulatory Roundup: EGFR, TROP2 Approvals and Broad IND A...
2/10/2026
AstraZeneca's China Business Hits New Heights as Record Revenue Boosts...
2/10/2026
China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse (IBD...
2/10/2026
China Overhauls Drug Administration Rules, Emphasizing Quality and Cli...
2/9/2026
Lilly Expands China Partnership With Innovent in New Global Oncology a...
2/9/2026
GenSci Advances Autoimmune Pipeline as NMPA Clears First IND for GenSc...
Page:
1
/
817
Total number of articles:
24501
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit